This company may still be operating, however this listing is no longer active. Find out why through their latest events.

QuiaPEG Pharmaceuticals Holding Past Earnings Performance

-20.0%

Earnings growth rate

16.5%

EPS growth rate

No updates

No updates

How QuiaPEG Pharmaceuticals Holding makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OM:QUIA BTU Revenue, expenses and earnings (SEK Millions)
Date	Revenue	Earnings	G+A Expenses
31 Dec 22	6	-20	16
30 Sep 22	6	-22	17
30 Jun 22	6	-22	17
31 Mar 22	7	-22	17
31 Dec 21	9	-20	16
30 Sep 21	8	-20	16
30 Jun 21	6	-24	19
31 Mar 21	6	-26	20
31 Dec 20	4	-28	21
30 Sep 20	5	-28	23
30 Jun 20	5	-24	21
31 Mar 20	4	-22	21
31 Dec 19	4	-20	20
30 Sep 19	1	-19	16
30 Jun 19	2	-15	14
31 Mar 19	3	-14	15
31 Dec 18	3	-12	14
30 Sep 18	8	-7	14
30 Jun 18	7	-7	12
31 Mar 18	5	-5	8
31 Dec 17	4	-4	8
31 Dec 16	2	-2	3

Quality Earnings: QUIA BTU is currently unprofitable.

Growing Profit Margin: QUIA BTU is currently unprofitable.

Earnings Trend: QUIA BTU is unprofitable, and losses have increased over the past 5 years at a rate of 20% per year.

Accelerating Growth: Unable to compare QUIA BTU's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: QUIA BTU is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-15.2%).

High ROE: QUIA BTU has a negative Return on Equity (-833.22%), as it is currently unprofitable.